197 related articles for article (PubMed ID: 824198)
21. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
Jose DG; Good RA
Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
[No Abstract] [Full Text] [Related]
22. An effector-cell independent step in target cell lysis by sensitized mouse lymphocytes.
Martz E; Benacerraf B
J Immunol; 1973 Nov; 111(5):1538-45. PubMed ID: 4200780
[No Abstract] [Full Text] [Related]
23. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.
Henney CS
J Immunol; 1971 Dec; 107(6):1558-66. PubMed ID: 5000987
[No Abstract] [Full Text] [Related]
24. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
Wright SC; Bonavida B
J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
[No Abstract] [Full Text] [Related]
25. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
Evans R; Alexander P
Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
[TBL] [Abstract][Full Text] [Related]
26. Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
Orsini F; Eppolito C; Ehrke MJ; Mihich E
Cancer Treat Rep; 1980; 64(2-3):211-8. PubMed ID: 6967756
[No Abstract] [Full Text] [Related]
27. Effect of carrageenan on the induction of cell-mediated cytotoxic responses in vivo.
Sakemi T; Kuroiwa A; Nomoto K
Immunology; 1980 Oct; 41(2):297-302. PubMed ID: 6969217
[TBL] [Abstract][Full Text] [Related]
28. Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity.
Fidler IJ; Gersten DM; Budmen MB
Cancer Res; 1976 Sep; 36(9 pt.1):3160-5. PubMed ID: 975082
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells.
Todd RF; Stulting RD; Berke G
Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536
[No Abstract] [Full Text] [Related]
30. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
Germain RN; Williams RM; Benacerraf B
Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of T cell-mediated cytotoxicity by anti-inflammatory steroids.
Schleimer RP; Jacques A; Shin HS; Lichtenstein LM; Plaut M
J Immunol; 1984 Jan; 132(1):266-71. PubMed ID: 6606668
[TBL] [Abstract][Full Text] [Related]
32. Studies on the mechanism of lymphocyte-mediated cytolysis. V. The use of cytochalasins A and B to dissociate glucose transport from the lytic event.
Bubbers JE; Henney CS
J Immunol; 1975 Jul; 115(1):145-49. PubMed ID: 807622
[TBL] [Abstract][Full Text] [Related]
33. Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture.
Ehrke MJ; Ryoyama K; Cohen SA
Cancer Res; 1984 Jun; 44(6):2497-504. PubMed ID: 6426781
[TBL] [Abstract][Full Text] [Related]
34. Combined effect of X irradiation and cell-mediated immune reaction.
Song CW; Guertin DP
Radiat Res; 1978 Sep; 75(3):586-92. PubMed ID: 103127
[No Abstract] [Full Text] [Related]
35. 7'-(3',4'-dihydroxyphenyl)-N-[(4-methoxyphenyl)ethyl]propenamide (Z23), an effective compound from the Chinese herb medicine Fissistigma oldhamii (Hemsl.) Merr, suppresses T cell-mediated immunity in vitro and in vivo.
Hu XD; Zhong XG; Zhang XH; Zhang YN; Zheng ZP; Zhou Y; Tang W; Yang Y; Yang YF; Hu LH; Zuo JP
Life Sci; 2007 Dec; 81(25-26):1677-84. PubMed ID: 18022200
[TBL] [Abstract][Full Text] [Related]
36. The effect of organophosphorus inhibitors, p-nitrophenol and cytochalasin B on cytotoxic killing of tumour cells by immune spleen cells, and the effect of shaking.
Ferluga J; Asherson GL; Becker EL
Immunology; 1972 Oct; 23(4):577-90. PubMed ID: 4628464
[TBL] [Abstract][Full Text] [Related]
37. [Effect of inhibitor-antioxidant of 3-hydroxypyridine series on cellular immunity].
Suzdal'tseva AA; Kapichnikov MM; Shalyminova IuA; Zykov IuV; Smirnov LD
Biull Eksp Biol Med; 1982 Feb; 93(2):49-50. PubMed ID: 7066526
[No Abstract] [Full Text] [Related]
38. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
39. In vivo suppression of the immune response to alloantigen by cholera enterotoxin.
Henney CS; Lichtenstein LM; Gillespie E; Rolley RT
J Clin Invest; 1973 Nov; 52(11):2853-7. PubMed ID: 4356000
[TBL] [Abstract][Full Text] [Related]
40. Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo.
Anaclerio A; Waterfield JD; Möller G
J Immunol; 1974 Sep; 113(3):870-5. PubMed ID: 4413847
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]